(Q40664719)

22 September 2017

1 reference

title

Clinical trials of varicella vaccine in healthy children (English)

1 reference

22 September 2017

White CJ

1

1 reference

22 September 2017

publication date

1 September 1996

1 reference

Infectious Disease Clinics of North America

22 September 2017

published in

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

595-608

1 reference

Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Live attenuated varicella vaccine: Immunization of healthy children with the OKA strain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Letter: Contact infection from live varicella vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Acyclovir treatment of varicella in otherwise healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

A controlled trial of acyclovir for chickenpox in normal children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Chickenpox hospitalizations among residents of Olmsted County, Minnesota, 1962 through 1981. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Lymphocyte responses to varicella zoster virus in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Diagnostic Skin Test Reactions with Varicella Virus Antigen and Clinical Application of the Test

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Selective decline in cellular immune response to varicella-zoster in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Varicella infection complicated with meningitis after immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Clinical and Laboratory Studies of KMcC Strain Live Attenuated Varicella Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Zoster in normal children after varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Antibody assays suitable for assessing immune responses to live varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Population-based study of herpes zoster and its sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Modification of chicken pox in family contacts by administration of gamma globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Enzyme-Linked Immunosorbent Assay for Susceptibility to Varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Live vaccine used to prevent the spread of varicella in children in hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970315-9

7 January 2021

10.1016/S0891-5520(05)70315-9

Identifiers

DOI

1 reference

22 September 2017

1 reference